Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Kelly

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthaseK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Biochemistry|July 23, 1996
Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazoleR M Chabin, E McCauley, J R Calaycay, et al.
The Medical Journal of Australia|October 6, 2001
Prevalence and nature of connexin 26 mutations in children with non-syndromic deafnessH H Dahl, K Saunders, T M Kelly, et al.
The Journal of Biological Chemistry|November 8, 1996
Expression and immunoaffinity purification of human inducible nitric-oxide synthase. Inhibition studies with 2-amino-5,6-dihydro-4H-1,3-thiazineJ R Calaycay, T M Kelly, K L MacNaul, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Substituted 2-aminopyridines as inhibitors of nitric oxide synthasesW K Hagmann, C G Caldwell, P Chen, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthaseK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Biochemistry|July 23, 1996
Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazoleR M Chabin, E McCauley, J R Calaycay, et al.
The Medical Journal of Australia|October 6, 2001
Prevalence and nature of connexin 26 mutations in children with non-syndromic deafnessH H Dahl, K Saunders, T M Kelly, et al.
The Journal of Biological Chemistry|November 8, 1996
Expression and immunoaffinity purification of human inducible nitric-oxide synthase. Inhibition studies with 2-amino-5,6-dihydro-4H-1,3-thiazineJ R Calaycay, T M Kelly, K L MacNaul, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Substituted 2-aminopyridines as inhibitors of nitric oxide synthasesW K Hagmann, C G Caldwell, P Chen, et al.
Pageof 7